A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy

被引：0
|
作者：
Rizk, Dana [1 ]
Perkovic, Vlado [2 ]
Lafayette, Richard A. [3 ]
Trimarchi, Hernan [4 ]
Barratt, Jonathan [5 ]
Carroll, Kevin [6 ]
Tesar, Vladimir [7 ]
Zhang, Hong [8 ]
Suzuki, Yusuke [9 ]
Liew, Adrian [10 ]
Wong, Muh Geot [11 ]
Leslie, Bruce R. [12 ]
Mathur, Mohit [13 ]
Hafkin, Jeffrey [12 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ New South Wales, Sydney, NSW, Australia
[3] Stanford Univ, Stanford, CA USA
[4] Hosp Britanico Buenos Aires, Buenos Aires, DF, Argentina
[5] Univ Leicester, Leicester, Leics, England
[6] KJC Stat, London, England
[7] Charles Univ Prague, Prague, Czech Republic
[8] Peking Univ, Beijing, Peoples R China
[9] Juntendo Daigaku, Bunkyo Ku, Tokyo, Japan
[10] Mt Elizabeth Novena Hosp, Singapore, Singapore
[11] Concord Repatriat Gen Hosp, Concord, NSW, Australia
[12] Otsuka Pharmaceut Dev Commercializat Inc, Rockville, MD USA
[13] Visterra Inc, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO712
引用
收藏
页码：799 / 799
页数：1
相关论文
共 50 条
  • [31] A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Samidorphan in Adults With Alcohol Dependence
    O'Malley, Stephanie
    Todtenkopf, Mark
    Ehrich, Elliot
    Silverman, Bernard L.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S276 - S276
  • [32] A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of Telitacicept in Patients with IgA Nephropathy and Persistent Proteinuria
    Lv, Jicheng
    Liu, Lijun
    Hao, Chuan-Ming
    Li, Guisen
    Fu, Ping
    Xing, Guangqun
    Zheng, Hongguang
    Chen, Nan
    Caili, Wang
    Luo, Ping
    Qiong, Xie D.
    Zuo, Li
    Wang, Yue
    Li, Rongshan
    Mao, Yonghui
    Dong Shaoshao
    Zhang, Pengfei
    Zheng, Hui X.
    Wang, Wenxiang
    Li, Lin
    Jiao, Wenjuan
    Fang, Jianmin
    Zhang, Hong
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B10 - B10
  • [33] A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis
    Lembo, Anthony
    Camilleri, Michael
    McCallum, Richard W.
    Sastre, Ramon F.
    Breton, Cristian F.
    Spence, Sharon C.
    White, Jeffery
    Gottesdiener, Keith
    Stoner, Elizabeth
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S158 - S159
  • [34] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
    Rovin, Brad H.
    van Vollenhoven, Ronald F.
    Aranow, Cynthia
    Wagner, Carrie
    Gordon, Robert
    Zhuang, Yanli
    Belkowski, Stanley
    Hsu, Benjamin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (09) : 2174 - 2183
  • [35] A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence
    Anton, Raymond F.
    Kranzler, Henry
    Breder, Christopher
    Marcus, Ronald N.
    Carson, William H.
    Han, Jian
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) : 5 - 12
  • [36] Efficacy and Safety of Inosine Pranobex in COVID-19 Patients: A Multicenter Phase 3 Randomized Double-Blind, Placebo-Controlled Trial
    Jayanthi, C. R.
    Swain, Ashok K.
    Ganga, Ranganath T.
    Halnor, Dnyaneshwar
    Avhad, Ajit
    Khan, Mohd Saif
    Ghosh, Ayan
    Choudhary, Sumer Sanjiv
    Yannawar, Anand Namdevrao
    Despande, Shubhangi
    Patel, Manish
    Anne, Krishna Prasad
    Bangar, Yogesh
    [J]. ADVANCED THERAPEUTICS, 2022, 5 (12)
  • [37] A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
    Nyhlin, H
    Bang, C
    Elsborg, L
    Silvennoinen, J
    Holme, I
    Rüegg, P
    Jones, J
    Wagner, A
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (02) : 119 - 126
  • [38] A double-blind, randomized, placebo-controlled, parallel study to evaluate the efficacy and safety of imidafenacin in patients with overactive bladder in Taiwan
    Chuang, Yao-Chi
    Lin, Chih-Chieh
    Chow, Po-Ming
    Lien, Chi-Shun
    Tsui, Ke-Hung
    Chou, Chieh-Lung
    Lee, Hsiang-Ying
    Meng, En
    Kuo, Hann-Chorng
    [J]. LUTS-LOWER URINARY TRACT SYMPTOMS, 2021, 13 (01) : 108 - 117
  • [39] A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a bupivacaine hydrochloride implant in patients undergoing abdominoplasty
    Beaton, Alina C.
    Solanki, Daneshvari
    Salazar, Hernan
    Folkerth, Steve
    Singla, Neil
    Minkowitz, Harold S.
    Leiman, David
    Vaughn, Ben
    Skuban, Nina
    Niebler, Gwendolyn
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2023, 48 (12) : 601 - 607
  • [40] Efficacy and safety of anamorelin HCl in NSCLC patients: Results from a randomized, double-blind, placebo-controlled, multicenter phase II study
    Temel, J.
    Bondarde, S.
    Jain, M.
    Allen, S.
    Mann, W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S269 - S270
12345